Olema Oncology Alternatives & Competitors

12 companies similar to Olema Oncology —

Sermonix Pharmaceuticals

Passion and purpose in women’s oncology

8 Series A $67.55M

Columbus, United States

Biopharma Pharmaceutical

Oncolix

Pioneering new horizons in ovarian cancer treatment with a focus on autophagy through our...

0-1 Venture round $8.46M

Biotechnology Health Care +1

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Repare Therapeutics

A leading precision oncology company focused on synthetic lethality

45 $607.40M

Montreal, Canada

Biotechnology Pharmaceutical

Compare

Track all Olema Oncology competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

39 Acquired $4.44M

United States

Biotechnology Health and Wellness +1

BriaCell Therapeutics Corp.

Developing Novel Therapies to Destroy Cancer

20 Post-IPO Equity $36.20M

Philadelphia, United Stat...

Biotechnology Health Care +2

Epsilogen Ltd

Harnessing the power of IgE

33 Series B $39.95M

United Kingdom

Biopharma Biotechnology +2

Glycyx

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...

3 Series A $7.10M

San Francisco, United Sta...

Biopharma Biotechnology +1

iOnctura

Developing precision small molecules to combat hard-to-treat tumors.

28 Series B $118.37M

Geneve, Switzerland

Biotechnology Health Care +2

Anchiano Therapeutics

Dedicated to the discovery, development, and commercialization of novel targeted therapies...

1 Post-IPO Equity $42.00M

Cambridge, United States

Biotechnology Health Care +1

About Olema Oncology

Olema Oncology is a biopharmaceutical company that focuses on developing innovative targeted therapies for women's cancers. Their lead program, OP-1250, is a potential best-in-class complete estrogen receptor antagonist (CERAN) designed to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2...

Taxonomy

Biopharmaceutical Company, Targeted Therapies, Women's Cancers, OP-1250, Estrogen Receptor Antagonist, Breast Cancer Treatment, Phase 1/2 Clinical Trial, Healthcare Investors, Pharmaceutical Development, Innovative Therapies, Clinical Research, Oncology, Biotech, Scientific Research

Frequently Asked Questions

Companies similar to Olema Oncology include Sermonix Pharmaceuticals, Oncolix, ORIC Pharmaceuticals Inc., Repare Therapeutics, Apollomics. They work in Biotechnology and Pharmaceutical and share Olema Oncology's focus on oncology, targeted therapies and clinical research.

Bounce Watch lists 12 companies that share Olema Oncology's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Olema Oncology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Olema Oncology Profile Sermonix Pharmaceuticals Alternatives ORIC Pharmaceuticals Inc. Alternatives Apollomics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Olema Oncology on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.